BUY Anthem Biosciences — Ashish Chaturmohta, 26 Aug 2026

byAshish Chaturmohta, JM FinancialHorizon: 1 year26 Aug 2026via CNBC Awaaz.

Entry₹894.1Inferred

Target₹1,100

Stop loss₹830-7.17% risk

CMP₹891.76h ago

Active-0.27%+23.36%upside left 11 mo left

Follow Ashish Chaturmohta for new calls(30% target hit, 10 closed calls)Get alerts Watch ANTHEM for new buy/sell callsGet alerts See 2 other Long-term calls on ANTHEM See 56 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 11:13 pm IST

11 supporting8 neutral1 opposing

Supports the BUY call (11)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·22 Sept · today

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·21 Aug · 1mo ago

Neutral / worth noting (8)

Anthem Biosciences, Shivalik Bimetal Garner Brokerage Attention

NewsGoogle News·27 Aug · 4w ago

Anthem Biosciences, Shivalik Bimetal: బ్రోకరేజ్ సంస్థల రేడార్‌లోకి కొత్త స్టాక్స్!

NewsGoogle News·27 Aug · 4w ago

JSW Steel, Anthem Biosciences ਅਤੇ eClerx: ਟੈਕਨੀਕਲ ਐਨਾਲਿਸਟ ਨੇ ਦਿੱਤੇ ਵੱਡੇ ਸੰਕੇਤ, ਜਾਣੋ ਕਿਹੜੇ ਲੈਵਲ 'ਤੇ ਰੱਖੀਏ ਨਜ਼ਰ

NewsGoogle News·27 Aug · 4w ago

Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Anthem Biosciences Limited — Ashish Chaturmohta, JM Financial

AI Assessment